Why the study?
Can noninvasive imaging methods using CMR and nuclear modalities effectively assess myocardial fibrosis in cardiomyopathies?
Can noninvasive imaging methods using CMR and nuclear modalities effectively assess myocardial fibrosis in cardiomyopathies?
Noninvasive imaging techniques like CMR T1/ECV mapping and molecular imaging offer promising methods for early detection and monitoring of myocardial fibrosis in cardiomyopathies.
No takes yet. Share an insight, caveat, or question.
May aid fibrosis assessment in cardiomyopathies; leaves open prospective validation before routine clinical adoption.
Won et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: